Published in Infect Immun on July 01, 1973
Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells. J Clin Microbiol (1977) 11.91
Interaction of chlamydiae and host cells in vitro. Microbiol Rev (1991) 8.10
The rôle of Chlamydia trachomatis in genital-tract and associated diseases. J Clin Pathol (1980) 6.42
Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect Immun (1978) 4.26
Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44
Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells). Infect Immun (1976) 3.11
The chlamydia: molecular biology of procaryotic obligate parasites of eucaryocytes. Microbiol Rev (1978) 2.43
Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol (1988) 2.41
An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest (1996) 2.35
Identification and properties of chlamydial polypeptides that bind eucaryotic cell surface components. J Bacteriol (1986) 1.93
Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells. Infect Immun (1988) 1.87
Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol (1984) 1.87
Ultrastructural study of mode of entry of Chlamydia psittaci into L-929 cells. Infect Immun (1986) 1.85
Differences in outer membrane proteins of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis. Infect Immun (1985) 1.84
Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract. J Clin Microbiol (1992) 1.70
Interaction between a trachoma strain of Chlamydia trachomatis and mouse fibroblasts (McCoy cells) in the absence of centrifugation. Infect Immun (1981) 1.58
Effect of methylamine and monodansylcadaverine on the susceptibility of McCoy cells to Chlamydia trachomatis infection. Infect Immun (1983) 1.57
Evidence that the major outer membrane protein of Chlamydia trachomatis is glycosylated. Infect Immun (1991) 1.34
Identification of Campylobacter jejuni surface proteins that bind to Eucaryotic cells in vitro. Infect Immun (1990) 1.32
Isolation and characterization of a mutant Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infect Immun (2001) 1.29
Mobilization of F-actin and clathrin during redistribution of Chlamydia trachomatis to an intracellular site in eucaryotic cells. Infect Immun (1991) 1.27
Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia. Infect Immun (1995) 1.27
Physicochemical surface properties of elementary bodies from different serotypes of chlamydia trachomatis and their interaction with mouse fibroblasts. Infect Immun (1982) 1.25
Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells. Infect Immun (1994) 1.22
Attachment and internalization of a Chlamydia trachomatis lymphogranuloma venereum strain by McCoy cells: kinetics of infectivity and effect of lectins and carbohydrates. Infect Immun (1983) 1.18
Influence of lectins, hexoses, and neuraminidase on the association of purified elementary bodies of Chlamydia trachomatis UW-31 with HeLa cells. Infect Immun (1983) 1.17
Identification of lectin-binding proteins in Chlamydia species. Infect Immun (1990) 1.15
Isoelectric focusing of Chlamydia trachomatis. Infect Immun (1979) 1.15
Selection of mutant cell lines resistant to infection by Chlamydia spp [corrected]. Infect Immun (2002) 1.09
The relation of basic biology to pathogenic potential in the genus Chlamydia. Infection (1982) 1.00
Improved method for isolation and growth of Chlamydia trachomatis in McCoy cells treated with cycloheximide using polyethylene glycol. J Clin Pathol (1985) 0.98
Recombinant Escherichia coli clones expressing Chlamydia trachomatis gene products attach to human endometrial epithelial cells. Infect Immun (1991) 0.96
Improved plaque assays for Rickettsia prowazekii in Vero 76 cells. J Clin Microbiol (1996) 0.93
Effect of polybrene on isolation of Chlamydia trachomatis from clinical specimens. J Clin Microbiol (1985) 0.88
A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA. J Clin Microbiol (1997) 0.87
Identification of the Chlamydia trachomatis RecA-encoding gene. Infect Immun (1995) 0.78
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development. J Bacteriol (1972) 11.22
The titration of trachoma and inclusion blennorrhoea viruses in cell cultures. J Gen Microbiol (1960) 4.86
Uptake of protein by mammalian cells: an underdeveloped area. The penetration of foreign proteins into mammalian cells can be measured and their functions explored. Science (1968) 3.06
Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95
Infection of cell cultures by trachoma agent: enhancement by DEAE-dextran. J Infect Dis (1971) 2.64
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. J Infect Dis (1972) 2.36
Plaque formation by Chlamydia in L cells. Infect Immun (1970) 2.09
A potency test for trachoma vaccine utilizing the mouse toxicity prevention test. Am J Ophthalmol (1967) 1.89
A membrane effect of basic polymers dependent on molecular size. Nature (1967) 1.77
Plaque enhancement of enteroviruses by magnesium chloride, cysteine, and pancreatin. J Bacteriol (1966) 1.70
Enhancing effect of DEAE-Dextran on inclusion counts of an ovine Chlamydia (Bedsonia) in cell culture. Aust J Exp Biol Med Sci (1970) 1.70
The continuous passage of agents of trachoma in cell culture. I. Characteristics of TW-3 and Bour strains of trachoma cultivated in serial passage in HeLa 229 cells. J Infect Dis (1966) 1.68
EGG INFECTIVITY ASSAY OF TRACHOMA VIRUS. Proc Soc Exp Biol Med (1964) 1.58
Antigenic variation in influenza virus. Biology and chemistry. Prog Med Virol (1971) 1.37
Studies on protein uptake by isolated tumor cells. 3. Apparent stimulations due to pH, hypertonicity, polycations, or dehydration and their relation to the enhanced penetration of infectious nucleic acids. J Cell Biol (1967) 1.33
Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nat New Biol (1971) 1.29
The effect of neuraminidase on the phagocytic process in human monocytes. Lab Invest (1966) 1.27
Electrophoretic behaviour of cells. Prog Biophys Mol Biol (1966) 1.02
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis (1974) 6.18
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun (1978) 4.03
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
Further Studies in Adult Rickets (Osteomalacia) and Foetal Rickets: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 3.56
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women. Br Med J (1978) 3.33
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet (1991) 2.75
A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 2.74
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Comparative susceptibility of eleven mammalian cell lines to infection with trachoma organisms. J Clin Microbiol (1975) 2.48
Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol (1988) 2.41
Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature (1994) 2.39
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. J Infect Dis (1972) 2.36
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27
Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a. J Infect Dis (1991) 2.26
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in Escherichia coli. Infect Immun (1985) 2.24
Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation (1994) 2.24
TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis (1988) 2.15
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15